1. Home
  2. SLNO vs KMT Comparison

SLNO vs KMT Comparison

Compare SLNO & KMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SLNO
  • KMT
  • Stock Information
  • Founded
  • SLNO 1999
  • KMT 1938
  • Country
  • SLNO United States
  • KMT United States
  • Employees
  • SLNO N/A
  • KMT N/A
  • Industry
  • SLNO Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • KMT Industrial Machinery/Components
  • Sector
  • SLNO Health Care
  • KMT Industrials
  • Exchange
  • SLNO Nasdaq
  • KMT Nasdaq
  • Market Cap
  • SLNO 1.9B
  • KMT 2.0B
  • IPO Year
  • SLNO 2014
  • KMT N/A
  • Fundamental
  • Price
  • SLNO $53.89
  • KMT $25.47
  • Analyst Decision
  • SLNO Strong Buy
  • KMT Sell
  • Analyst Count
  • SLNO 7
  • KMT 6
  • Target Price
  • SLNO $68.71
  • KMT $24.33
  • AVG Volume (30 Days)
  • SLNO 803.1K
  • KMT 628.1K
  • Earning Date
  • SLNO 11-05-2024
  • KMT 11-06-2024
  • Dividend Yield
  • SLNO N/A
  • KMT 3.15%
  • EPS Growth
  • SLNO N/A
  • KMT N/A
  • EPS
  • SLNO N/A
  • KMT 1.37
  • Revenue
  • SLNO N/A
  • KMT $2,046,899,000.00
  • Revenue This Year
  • SLNO N/A
  • KMT $1.03
  • Revenue Next Year
  • SLNO N/A
  • KMT $2.27
  • P/E Ratio
  • SLNO N/A
  • KMT $18.54
  • Revenue Growth
  • SLNO N/A
  • KMT N/A
  • 52 Week Low
  • SLNO $21.30
  • KMT $22.08
  • 52 Week High
  • SLNO $56.81
  • KMT $27.04
  • Technical
  • Relative Strength Index (RSI)
  • SLNO 57.97
  • KMT 50.08
  • Support Level
  • SLNO $53.02
  • KMT $25.03
  • Resistance Level
  • SLNO $54.86
  • KMT $26.18
  • Average True Range (ATR)
  • SLNO 2.13
  • KMT 0.51
  • MACD
  • SLNO 0.23
  • KMT 0.01
  • Stochastic Oscillator
  • SLNO 68.82
  • KMT 56.71

About SLNO Soleno Therapeutics Inc.

Soleno Therapeutics Inc is focused on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its product candidates comprise Diazoxide Choline Controlled-Release tablets, which is an oral tablet for the treatment of Prader-Willi Syndrome. DCCR tablets consist of the active ingredient diazoxide choline, a choline salt of diazoxide, which is a benzothiadiazine.

About KMT Kennametal Inc.

Kennametal Inc is a manufacturer of metalworking tools and wear-resistant engineered components and coatings. The company operates in two business segments; Metal Cutting and Infrastructure. It generates maximum revenue from the Metal Cutting segment. The Metal Cutting segment develops and manufactures high-performance tooling and metal cutting products and services and offers an assortment of standard and custom metal cutting solutions to diverse end markets, including aerospace, general engineering, energy, and transportation. Geographically, it derives maximum revenue from the United States and the rest from Germany, China, Canada, India, Italy, and other countries.

Share on Social Networks: